Argobio SAS Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2021

Location

Paris France

Primary Industry

Biotechnology

About

Based in Paris, France, and founded in 2021, Argobio, SAS operates a start-up studio intended to fund start-up companies dedicated to biotechnological therapeutic products. Argobio was initiated by Kurma Partners, a leading Paris-based healthcare venture capital firm, and Bpifrance, the French national investment bank, the two investors just formalized their alliance in the field of life science. Argobio is led by an experienced group of biotech entrepreneurs, experts in biotechnologies, who will identify innovative technologies from a wide European network of research institutions to be turned into high-potential companies. The internal team is led by Yves Ribeill, Neill Mackenzie, and Rémi Soula. Thierry Laugel, Managing Partner at Kurma Partners is the President of Argobio. In March 2021, the company raised funding from Kurma Partners, Bpifrance, Angelini Pharma, Evotec, and the Institut Pasteur. Argobio identifies, selects, and incubates early-stage biotechnology projects that focus on selected therapeutic areas such as rare diseases, neurological disorders, oncology, and immunology, allowing startup companies to further develop their medicinal and drug research process. The investors will have an option to invest in the biotech companies created by Argobio. The March 2021 investment received by Argobio is part of an open innovation strategy that aims to create collaboration agreements. The company will create and launch at least five biotech companies over the next five years sourcing innovative early-stage projects from European academic research institutions.

Current Investors

Institut Pasteur, Angelini Investments, Evotec SE

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Consulting Services, Private Equity, Biopharmaceuticals

Website

www.argobiostudio.com

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.